Quantcast

Latest Food and Drug Administration Stories

2014-10-08 16:27:08

DUBLIN, October 8, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/m9tbs3/us_orphan_drug) have announced the addition of the "US Orphan Drug Clinical Pipeline Insight 2014" [http://www.researchandmarkets.com/research/m9tbs3/us_orphan_drug ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Rare diseases are also known as Orphan diseases. These diseases are generally categorized as chronic,...

2014-10-08 08:27:59

New Device Featured at the European Academy of Dermatology and Venereology* WAYLAND, Massachusetts, October 8, 2014 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ:ELOS), a leading global aesthetic device company, announced today the international launch of the new PicoWay(TM) picosecond device at the 23rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam, The Netherlands, October 8-12, 2014. PicoWay is a state-of-the-art dual wavelength device, with...

2014-10-08 08:26:46

SAN DIEGO, Oct. 8, 2014 /PRNewswire/ -- Suneva Medical, Inc., a privately-held aesthetics company, today announced the appointment of Peter Barton Hutt as a member of its Board of Directors. Known in the legal community as the "dean of the food and drug bar," Mr. Hutt has been a leading food and drug law practitioner and scholar for half a century. Mr. Hutt has specialized in food and drug law at the Washington D.C. firm of Covington and Burling since 1960, pausing only to serve as...

2014-10-07 12:32:27

Speakers include Chimerix President and CEO M. Michelle Berrey, M.D., M.P.H. and Noted Ethicist Arthur L. Caplan, Ph.D. PRINCETON, N.J., Oct. 7, 2014 /PRNewswire/ -- WIRB-Copernicus Group (WCG), the world's largest provider of regulatory and ethical review services and software to support clinical research, announced that it will be hosting a webinar entitled, "Early Access to Investigational Drugs: Lessons from Ebola," at 3:00 p.m. EDT today....

2014-10-07 08:30:22

MILFORD, Pa., Oct. 7, 2014 /PRNewswire/ -- Manzo Pharmaceuticals, Inc. (OTCPink:FOGCD), today announced that after discussions with the Food and Drug Administration, it has been determined that its long lasting lactose digestive aid, Lacto-Freedom(TM), will not need FDA approval to be released to the public. The FDA considers the probiotic to be a dietary "supplement", and therefore outside the scope of a very long and expensive FDA approval process that would be required if the...

2014-10-07 08:29:00

NEW YORK and PETACH TIKVAH, Israel, Oct. 7, 2014 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that the United States Food and Drug Administration (FDA) has designated NurOwn(TM) as a Fast Track product for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease). NurOwn(TM) consists of autologous mesenchymal stem cells that have been induced to...

2014-10-06 23:08:54

As Testosterone Complaints Continue to Increase, the FDA Furthers Its Investigation into Testosterone Use by Holding a Meeting of Its Advisory Panels to Explore the Safety and Effectiveness of Testosterone Products Detroit MI (PRWEB) October 06, 2014 As testosterone lawsuit litigation moves into the discovery phase in the U.S. District Court, Northern District of Illinois, the Oliver Law Group P.C. reports that the number of testosterone lawsuit filings have increased 13 percent in the...

2014-10-06 23:00:19

FDA Reviewing the Safety of AndroGel and Other Approved Low Testosterone Treatments after Studies Linked Their Use to a Higher Risk of Heart Attacks, Strokes and Death in Certain Men Columbus, OH (PRWEB) October 07, 2014 As concerns surrounding the cardiovascular side effects of AndroGel and other currently approved low testosterone treatments continue to grow, Wright & Schulte LLC notes that one pharmaceutical company is positioning its experimental medication as a superior...

2014-10-06 16:22:57

Studies such as this examination of statistical associations have no capability to establish cause-and-effect relationships WASHINGTON, Oct. 6, 2014 /PRNewswire-USNewswire/ -- The American Chemistry Council (ACC) offers the following comments regarding the study published today in JAMA Pediatrics by A. Spanier, et al, entitled "Bisphenol A Exposure and the Development of Wheeze and Lung Function in Children Through Age 5 Years." Quotes from the following may be attributed to Steven...

2014-10-06 12:25:17

NEW YORK, Oct. 6, 2014 /PRNewswire/ -- The FDA's grant of permission of "expanded access" to Tekmira to administer an experimental medicine for Ebola highlights not only the grave threat the disease outbreak presents, but also the difficulty of bringing life-saving products such as vaccines to market, according to Kalorama Information. The healthcare market research publisher studied vaccine production in its recent report, Biopharmaceutical and Vaccine Production Markets....


Latest Food and Drug Administration Reference Libraries

Flavr Savr
2013-10-03 09:43:32

Flavr Savr, also known as CGN-89564, a genetically modified tomato, was the first commercially grown genetically engineered food to be granted a license for human consumption. It was produced by the Californian company Calgene, and submitted to the U.S. Food and Drug Administration in 1992. On May 18, 1994, the FDA completed its evaluation of the Flavr Savr tomato and the usage of APH(3’)II, concluding that the tomato “is as safe as tomatoes bred by conventional means” and “that the...

Chilean Sea Bass, Dissostichus eleginoides
2013-01-12 08:49:28

The Chilean sea bass is the North American name for the Patagonian toothfish. The Chilean sea bass name derived in 1977 from Lee Lantz, a fish wholesaler looking for a more attractive name for the American fish market. In 1994 the Food and Drug Administration (FDA) accepted the Chilean sea bass as an alternative name for the Patagonian toothfish. This species is native to the southern Pacific, Atlantic, and Indian Oceans, around seamounts and continental shelves in the colder waters. The...

More Articles (2 articles) »
Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related